We are live on
!
Find out more
TC
Trilogy Capital Portfolio holdings
AUM
$2.58B
1-Year Est. Return
22.97%
This Fund
S&P 500
This Quarter
Est. Return
-9.42%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
–
AUM
$743M
AUM Growth
-$64.7M
(-8%)
Cap. Flow
+$15.3M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
50.59%
Holding
662
New
7
Increased
37
Reduced
82
Closed
529
Top Buys
Top Sells
Sector Composition
| 1 | Utilities | 1.42% |
| 2 | Consumer Staples | 1% |
| 3 | Healthcare | 0.65% |
| 4 | Technology | 0.47% |
| 5 | Financials | 0.47% |
Similar funds
GFA
LS
RG
AAS
CWS
DCM
GWP
PCM
Trilogy Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Trilogy Capital held 662 positions worth $743M, down 8% from $808M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Trilogy Capital's Q4 2018 filing shows 7 new, 37 increased, 82 reduced and 529 closed positions. Its largest new stake was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M. The largest sale was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $13.2M.
By sector, the portfolio is most concentrated in Utilities at 1.4% of assets, down from 1.4% a quarter earlier, followed by Consumer Staples and Healthcare.
- Trilogy Capital's largest Q4 2018 buy was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M.
- Trilogy Capital added most to State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2018, an estimated $12.8M increase.
- Trilogy Capital's biggest Q4 2018 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $13.2M.
- Trilogy Capital fully exited John Hancock Multifactor Mid Cap ETF in Q4 2018, selling an estimated $11.1M.
- Trilogy Capital's ten largest holdings make up 51% of its $743M portfolio in Q4 2018.
- Trilogy Capital opened 7 new positions and closed 529 in Q4 2018.
- Trilogy Capital's portfolio value fell 8% quarter-over-quarter to $743M.
Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.